Motoki Yano

Motoki Yano

Auto-generated profile, based on publicly available information

Motoki Yano

Division of Chest Surgery, Department of Surgery, Aichi Medical University, Nagakute, Aichi, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
SMSatoru Moriyama
Satoru Moriyama
MYMotoki Yano
Motoki Yano
HHHiroshi Haneda
Hiroshi Haneda
KOKatsuhiro Okuda
Katsuhiro Okuda
OKOsamu Kawano
Osamu Kawano
RNRyoichi Nakanishi
Ryoichi Nakanishi
Background: Pure red cell aplasia (PRCA) associated with thymoma is relatively rare, and relevant reports are limited. We investigated the clinical features and outcomes of PRCA associated with thymoma in this study. Methods: A retrospective review of all PRCA patients who underwent surgical resection of thymoma from April 1, 2004, to December 31, 2015, was performed. Results: We experienced eight patients with PRCA among 146 patients who underwent surgical resection of thymoma. Extended thymectomy (n=4) and thymectomy (n=4) were performed for thymoma. Regarding the WHO classification of thymoma, the subtypes were type B2 or B3 in seven patients, and the stage of thymoma was advanced in seven patients. Complete resection was achieved macroscopically in only five patients. Recurrence of thymoma occurred in four patients who underwent complete resection. PRCA was diagnosed after surgical resection of thymoma in six patients (range 1–101 months, median 56.5 months). Cyclosporine was used for PRCA in six patients. Pneumonia of treatment-related complications due to cyclosporine occurred in all patients. The follow-up period ranged from 13–147 months (median 54.5 months) after the PRCA diagnosis. Three patients obtained complete remission of anemia by cyclosporine. Although one patient was able to stop taking cyclosporine because of complete remission of anemia, transfusion was needed due to relapse of PRCA. Five patients died, with the main causes of death diagnosed as pneumonia (n=4) and cardiac failure (n=1). Conclusions: PRCA associated with thymoma was diagnosed postoperatively in three-quarter of patients. We should be alert for the occurrence of PRCA even after resection of thymoma, especially in patients with incomplete resection or advanced disease. Cyclosporine was effective for PRCA, but treatment-related complications occurred, particularly pneumonia. As treatment for PRCA associated with thymoma and its complications were combined in a complex manner, treating PRCA associated with thymoma can be quite difficult.

21 March 2017 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MYMotoki Yano
Motoki Yano
YFYoshitaka Fujii
Yoshitaka Fujii
JYJunji Yoshida
Junji Yoshida
TUTomoki Utsumi
Tomoki Utsumi
HSHiroyuki Shiono
Hiroyuki Shiono
YSYushi Saito
Yushi Saito

23 August 2012 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MSMasayuki Shitara
Masayuki Shitara
HSHidefumi Sasaki
Hidefumi Sasaki
KYKeisuke Yokota
Keisuke Yokota
KOKatsuhiro Okuda
Katsuhiro Okuda
YHYu Hikosaka
Yu Hikosaka
YFYoshitaka Fujii
Yoshitaka Fujii
The epidermal growth factor receptor (EGFR) gene is highly polymorphic and its expression and activity may be affected by various polymorphisms. There have been several studies examining associations between EGFR polymorphisms and clinical outcome of lung cancer therapy; however, the underlying mechanism is largely unknown. The present study investigated EGFR polymorphism status and its correlation with clinicopathological features in Japanese non-small cell lung cancer (NSCLC) patients. We investigated 5 polymorphisms in the EGFR gene (-216G/T, -191C/A, 8227G/A, D994D and R497K) in 274 surgically-treated NSCLC patients. TaqMan single nucleotide polymorphism (SNP) genotyping assays and a PCR-based assay were used to analyze these polymorphisms. In our cohort of patients we did not find any evidence of the -191C/A polymorphism. Our results showed that the patients with the 8227GA or AA type in intron 1 had a significantly better prognosis with the anti-EGFR therapy than the patients with the GG type (p=0.0448) in terms of recurrence of lung cancer. No significant association was observed between 3 other SNPs (-216G/T, D994D and R497K) and clinicopathological features. The EGFR 8227G/A polymorphism in intron 1 may be associated with clinical outcome in NSCLC patients treated with EGFR tyrosine kinase inhibitors.

17 January 2019 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
MYMotoki Yano
Motoki Yano
HNHiroki Numanami
Hiroki Numanami
TATakashi Akiyama
Takashi Akiyama
RTRumiko Taguchi
Rumiko Taguchi
CFChihiro Furuta
Chihiro Furuta
MHMasayuki Haniuda
Masayuki Haniuda

1 May 2020 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
MYMotoki Yano
Motoki Yano
HNHiroki Numanami
Hiroki Numanami
TATakashi Akiyama
Takashi Akiyama
RTRumiko Taguchi
Rumiko Taguchi
CFChihiro Furuta
Chihiro Furuta
MHMasayuki Haniuda
Masayuki Haniuda
Background: Descending necrotizing mediastinitis (DNM) resulting from oropharyngeal and cervical abscess is a life-threatening condition. This study attempted to improve our recognition of the extension and distribution of the abscess for ideal thoracic drainage. Methods: We performed a retrospective clinical analysis of seven patients who underwent thoracic drainage for DNM with available clinical data. For mapping and classification of the distribution of the abscess, computed tomography and intraoperative findings were utilized. Results: To cure patients, cervical drainage and thoracic drainage were performed 14 and 11 times, respectively. The operation time for thoracic drainage and intraoperative blood loss were 141±77 min and 103±103 g, respectively. The mean hospital stay was 66±41 days. All patients are alive without recurrence. We divided the abscess distribution into nine categories including the anterior thoracic wall, according to the computed tomography and intraoperative findings. The rate of abscess descended gradually toward the lower mediastinum. Abscesses were not necessarily continuous, and skipped lesions were occasionally noted. Conclusions: We were able to cure all seven patients with DNM. It might be helpful to recognize the exact distribution of the abscess and distribution-specific drainage using a new map and classification of thoracic abscess.

1 March 2021 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
TATakashi Akiyama
Takashi Akiyama
MYMotoki Yano
Motoki Yano
HNHiroki Numanami
Hiroki Numanami
MYMasayuki Yamaji
Masayuki Yamaji
RTRumiko Taguchi
Rumiko Taguchi
MHMasayuki Haniuda
Masayuki Haniuda
Background: We sometimes experience postoperative surgical site infection (SSI) at the chest tube drainage site (CDS) after thoracotomy. The incidence of and risk factors for SSI at the CDS have remained unclear. Methods: We conducted a prospective study to determine the incidence and risk factors for SSI at the CDS. We analyzed 99 patients who underwent lobectomy or segmentectomy for pulmonary malignant lesions. Results: There were 56 males and 43 females with an average age of 71 years. The postoperative drainage period was 2–15 days. Bacterial species were detected in secretions in 18 of 99 cases (18.2%). Older age was a risk factor for the detection of bacteria at the timing of chest tube removal. Eighteen cases (18.2%) were diagnosed with presence of SSI at the CDS at the timing of staple or suture removal. A pathological diagnosis of squamous cell carcinoma was regarded as a candidate risk factor for SSI. Eleven of 18 SSI patients showed delayed wound healing. A higher level of HbA1c was found in patients with delayed wound healing. Enterococcus faecalis infection may influence the development of complex SSI. Conclusions: We identified the bacterial profiles, incidence of and risk factors for SSI at the CDS. More intense preoperative glycemic control and an understanding of the bacterial profile and may be useful for reducing the incidence of SSI chest tube drainage sites (CDS).